Investor Stock List
Ranked #8,331 of 8,699 institutional investors

Empery Asset Management, LP

New York, NY

$68.0M
US stock portfolio at live prices · today +$879K (+1.31%)
Live prices, last trade 10:03 AM ET
Value at quarter end (Q3 2026)
$81.4M
Change from Q2 2026
−$5.1M (−5.86%)
Positions
23 · 7 new, 5 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $972K of stock, put options on $14.1M. $3.1M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
XFOR 43.5%EMPD 13.8%OTLK 12.3%NGEN 9.34%PYXS 2.78%
StockSharesValue, live% of portfoliovs Q2 2026
XFOR X4 Pharmaceuticals, Inc.9,725,509$29.6M43.5%Added +40%
EMPD Empery Digital Inc.4,830,345$9.4M13.8%Added +65%
OTLK Outlook Therapeutics, Inc.21,247,856$8.4M12.3%New
NGEN NervGen Pharma Corp.3,308,973$6.4M9.34%Reduced −17%
PYXS Pyxis Oncology, Inc.1,000,000$1.9M2.78%New
AMLX Amylyx Pharmaceuticals, Inc.60,000$1.6M2.31%New
DYAI Dyadic International, Inc.3,346,275$1.1M1.65%New
CLRB Cellectar Biosciences, Inc.955,118$841K1.24%Added +404%
CLNN Clene Inc.221,660$731K1.08%Reduced −76%
QNRX Quoin Pharmaceuticals, Ltd.204,910$717K1.05%New
DTIL Precision BioSciences, Inc.102,292$713K1.05%Reduced −87%
TNYA Tenaya Therapeutics, Inc.2,128,726$670K0.98%Reduced −45%
FEMY Femasys Inc.468,750$591K0.87%New
GLNDW Greenland Energy Company1,000,000$486K0.71%Unchanged
MSLE Satellos Bioscience Inc.58,000$342K0.50%Reduced −46%
URG Ur-Energy Inc.620,136$312K0.46%Unchanged
CYN Cyngn Inc.1,310,422$299K0.44%Added +41%
GOSS Gossamer Bio, Inc.24,954$279K0.41%New
BCTXL BriaCell Therapeutics Corp.300,000$252K0.37%Unchanged
JAGU Jaguar Uranium Corp.345,580$240K0.35%Reduced −29%
LTRN Lantern Pharma Inc.543,337$152K0.22%Reduced −36%
DUKRW DUKE Robotics Corp.35,000$15K<0.1%Unchanged
MDAIW Spectral AI, Inc.33,336$10K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
AMC AMC Entertainment Holdings, Inc.1,714,043$4.7M
ANVS Annovis Bio, Inc.2,401,476$1.8M
VENU Venu Holding Corp512,818$533K
SCYX SCYNEXIS, Inc.126,451$329K
RNTX Rein Therapeutics Inc.370,834$142K